MAGN
Magnera CorpPrice & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Free cash flow non-GAAP | $73M | March Quarter | — |
| adjusted free cash flow non-GAAP | $128M | the last 12 months call | — |
| debt paydown | $36M | the quarter call | — |
| free cash flow yield non-GAAP | 40% | the last 12 months call | — |
| year-over-year volume change (rest of the world) | -4% | the quarter call | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Household & Personal Products — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MAGN
this stock
Magnera Corp
|
$448.22M | -14.8% | +46.5% | — | 8.1% |
|
PG
PROCTER & GAMBLE Co
|
$342.40B | +3.2% | +0.3% | 21.5 | 1.0% |
|
UL
Unilever PLC
|
$132.99B | -4.0% | — | — | 0.1% |
|
CL
Colgate Palmolive Co
|
$74.05B | +17.4% | +1.7% | 35.9 | 2.2% |
|
KMB
Kimberly Clark Corp
|
$37.53B | +12.8% | -15.0% | 17.8 | 12.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MAGN | +2.5% | +7.5% | -14.5% | +9.8% | -14.8% |
| SPY | +0.8% | +2.0% | +8.9% | +0.7% | +10.2% |
| vs SPY | +1.7% | +5.5% | -23.4% | +9.1% | -25.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.